Map pointer

3855 SW 153rd Drive, Beaverton, Oregon 97003

Email icon

Membership Participation

Membership Participation

Participating in the Consortium

The activities and efforts of the Subcutaneous Drug Development and Delivery Consortium provide an opportunity for participating organizations to proactively impact and drive value across SC drug development and delivery and ultimately provide value to the larger community.

SC Consortium Officers:

Donna French, PhD

President

Sachin Mittal, PhD

Vice President

Monica Adams, PhD

Marketing Officer

David Kang, PhD

Treasurer

SC Consortium: Tier 1 Members

BMS TIER 1

SC Consortium: Tier 2 Members

Koru
Nemera

SC Consortium: Governing Board/Tier 1 Members

PFIZER

Executive Director – Drug Product Design & Development

Head – Nanoparticle Development

ROCHE

Global Head Product Optimiatzation

SC Consortium CDRS Co-lead

HALOZYME

Associate Director, Drug Delivery
SC Consortium Treasurer

ASTRA ZENECA

Vice President, Dosage Form Design & Development
SC Consortium President

ASTRA ZENECA

 

Senior Director,  Astra Zeneca

SC Consortium Sustainability Co-lead

SANOFI

Global Head of Device Development Portfolio

YPSOMED

Vice President

Head of Account and Business Development

BOEHRINGER INGELHEIM

Head

Scientific Excellence and Engagement Development

The SC Consortium has been proudly engaging with Charles Rivers Associates since its inception in 2018

Robert Broadnax
NJ

Vice President

PROJECT LEAD
Brian Carpenter
NJ

Principal

PROJECT LEAD
Matthew Potter
NY

Senior Associate

ENGAGEMENT LEAD
Ella Brown
SF

Consulting Associate

PROJECT SUPPORT
en_USEnglish